Fournel, Sylvie et al., “Soluble HLA-G: Purification from Eukaryotic Transfected Cells and Detection by a Specific ELISA”; American Journal of Reproductive Immunology, vol. 42, No. 1, Jul. 1999, pp. 22-29. |
Jurisicova Andrea et al., “Variability in the expression of trophectodermal markers β-human chorionic gonadotrophin, human leukocyte antigen-G and pregnancy specific β-1 glycoprotein by thr human blastocyst”; Human Reproduction, vol. 14, No. 7, Jul. 1999, pp. 1852-1858. |
Mallet Valerie et al., “Primary cultured human thymic epithelial cells express both membrane-bound and soluble HLA-G translated products”; Journal of Reproductive Immunology, vol. 43, No. 2, Jul. 1999, pp. 225-234. |
Cross et al., “Implantation and the Placenta: Key Pieces of the Development Puzzle,” Dec. 2, 1994, Science, vol. 266: 1508-1518. |
Sherman, et al., “The Molecular Basis of Allorecognition,” (1993), Annu. Rev. Immunol. 11: 385-402. |
Geraghty et al., “A Human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment:,” Proc. Natl. Acad. Sci. U.S.A., vol. 84, pp. 9145-9149, Dec. 1987. |
Parham et al., “Nature of polymorphism in HLA-A, -B, and -C molecules,” Proc. Natl. Acad. Sci. U.S.A., vol. 85, pp. 4005-4009, Jun. 1988, Immunology. |
Shimizu et al., “Transfer and expression of three cloned humna non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells,” Proc. Natl. Acad. Sci. U.S.A. 85, pp. 227-231, Jan. 1988, Immunology. |
Ishitani and Geraghty, “Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and II antigens,” Proc. Natl. Acad. Sci., U.S.A., vol. 89, pp., 3947-3951, May 1992, Immunology. |
Kirszenbaum et al.., “An alternatively spliced form of HLA-G mRNA in humna trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes,” Proc. Natl. Acad. Sci., U.S.A., vol. 91, pp. 4209-4213, May 1994, Immunology. |
Fujii et al., A Soluble Form of the HLA-G Antigen is Encoded by a Messenger Ribonucleic Acid Containing Intron 4 (1994) J. Immunol. 153: 5516-5524, Sep. 1994. |
Van der Ven and Ober, “HLA-G Polymorphisms in African Americans,” J. Immunol. 153:5628-5633, Sep. 1994. |
Rochat R.W., et al., “Material Morality in the United States: Report form the Material Mortality Collaborative,” Obstet Gynecol, 72(1):91-97. |
Redman C.W. Current Topic: Pre-eclampsia and the Placenta, Placenta (1991), 12(4):301-308. |
Chun D., et al., Clinical Observations on Some Aspects of Hydatidiform Moles J. Obstet.. Gynecol. Br. Commonw. 1964: 71: 180-184. |
Redman C.W.G., “Immunology of Preeclampsia,”Semin Perinatol, vol. 15, Jun. 1991, 15(3):257-62. |
Jurisicova A., et al., “Embryonic human leukocyte antigen-G expression: possible implications for human preimplantation development,” Fertil. Steril., 65(5):997-1002, May 1996. |
Jurisicova A., et al., “HLA-G expression durign preimplantation hyman embryo development,” Proc. Natl. Acad. Sci. U.S.A., vol. 93, pp. 161-165, Jan. 1996, Developmental Biology. |
Leese H.J., et al., Early human embryo metabolism,: Bioessays, vol. 15(4), pp. 259-264, Apr. 1993. |
McMaster M., et al., “Human Placental HLA-G Expression is Restricted to Differentiated Cytotrophoblasts,” J. Immunology. 154-3771-3778, 1995. |
AbouZahr C., et al, in 1996 Maternal Mortality. World Health Stat Q, 49(2): 77-87. |
Redman, C.W.G., “The Immunology of Preclampsia,” in Immunology of Pregnancy, edt by Chaout G, CRC press, Boca Raton, pp. 205-230, 1993. |
Kupferminc, M.J. et al., “Tumor necrosis factor-α is elevated in plasma and amniotic fluid of patients with severe preeclampsia,” Am. J. Obstet. Gynecol. 1994: 170(6): 1752-1759. |
Sunder-Plassmann, G. et al., “Increased Serum activity of interleukin-2 in patients with preeclampsia,” J. Autoimmunity, 2(2): 203-205, Apr. 1989. |
Hara, N. Fuji et al., “Histochemical Demonstration of Interleukin-2 in Decidua Cells of Patients with Preeclampsia,” Am. J. Reprod. Immunol. 1995: 34: 44-51. |
Hara, N. Fuji et al., “Altered Expression of Human Leukocyte Antigen G (HLA-G) on Extravillous Trophoblasts in Preeclampsia: Immunohistological Demonstration with anti-HLA-G Specific Antibody “87G” and Anti-cytokeratin Antibody ‘CAM5.2,’” Am. J. Reprod. Immunol. 1996: 36: 349-358. |
Lim, KH et al., “Human Cytotrophoblast Differentiation/Invasion is Abnormal in Preeclampsia,” A. J. Pathol. 1997: 151: 1809-1818. |
Ellis, Shirley, “HLA G: At the interface,” Am. J. Reprod. Immunol. 1990: 23: 84-86. |
Loke, Y. W., “Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody,” Tissue Antigen 1997: 50: 135-146. |
Kovats, Susan et al., “A Clas I Antigen, HLA-G, Expressed in Human Trophoblasts,” Science 1990: 248: 220-223. |
Chumbley, Gill et al., “Resistance of HLA-G and HLA-A2 Transfectants to Lysis by Decidual NK Cells,” Cell Immunol. 1994: 155: 312-322. |
Deniz, Gunnur et al., “Phenotypic and Functional Cellular Difference Between Human CD3-Decidual and Peripheral Blood Leukocytes,” J. Immunol. 1994: 152: 4255-4261. |
Sanders, S.K. et al., “Cell-Cell Adhesion Mediated by CD8 and Juman Histocompatibility Leukocyte Antigen G, a Nonclassical Major Histocompatibility Complex Class 1 Molecule on Cytotrophoblasts,” J. Exp. Med., 1991: 174: 737-740. |
Chesley, Leon C., Editorial, “Diagnosis of Preeclampsia,” Obstet. Gynecol, Mar. 1985: vol. 65(3): 423-425. |
McMaster, Michael et al, “HLA-G Isoforms Produced by Placental Cytotrophoblasts and Found in Amniotic Fluid are Due to Unusual Glycosylation,” J. Immunol. 1998: 160: 5922-5928. |
Laemmli, U.K, “Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4,” Nature—Aug. 15, 1970, vol. 227, pp. 680-685. |
Harlow E. Lane D: Monoclonal Antibodies. In Antibodies: a laboratory manual. edt. By Harrow E. and Lane D., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 139-149. |
Colbern, Gail T. et al., “Expression of the nonclassic histocompatibility antigen HLA-G by preeclampsia placenta,” Am. J. Obstet. Gynecol 1994: 170: 1244-1250. |
Le Bouteiller, P. et al., “Antigen-presenting function(s) of he non-classical HLA-E, -F and -G class I molecules: the beginning of a story,” Res. Immunol. 1996: 147: 301-312. |
Crisa, Laura et al., “Identification of a Thymic Epithelial Cell Subset Sharing Expression of the Class Ib HLA-G Molecule with Fetal Trophoblasts,” J. Exp. Med. 1997: 186: 289-298. |
Omu, Alexander E. et al., “Effect of Antihypertensive Therapy in Preeclampsia on Levels of Serum Interleukin-4,” Gynecol. Obstet. Invest. 1996: 42: 230-236. |
Clark, David A., Editorial, HLA-G Finally Does Something!, Am. J. Reprod. Immunol. 1997: 38: 75-78. |
Maejima, M. et al., “Presence of HLA-G Expressing Cells Modulates the Ability of Peripheral Blood Mononuclear Cells to Release Cytokines,” Am. J. Reprod. Immunol., 1997: 38: 79-82. |
Rebmann et al., “Detection of soluble HLA-G molecules in plasma and amniotic fluid”, Tissue Antigens 53: 14-22, Jan. 1999. |
Hellstrom et al., “Monoclonal antibodies for cancer detection and therapy” (Baldwin et al., eds.), Academic Press, London, 1985, p. 20. |
Geraghty et al., Production Of Monoclonal Antibodies Specific For The New Class I Antigen HLA-G And Their Use To Examine Expression In Trophoblast Cells, FASEB Journal 4(7): A2216, Abstract #3016, 1990. |